NCT01222923View on ClinicalTrials.gov

Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

January 31, 2005

Conditions
Healthy
Interventions
DRUG

Risperidone

1 mg orally disintegrating tablets

Trial Locations (1)

27517

aaiPharma Inc., Chapel Hill

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT01222923 - Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter